Urinary excretion of apo(a) fragments in NIDDM patients

Diabetologia

Volumn 40, Issue 12, 1997, Pages 1455-1460

  Clodi, M ^a   Oberbauer, R ^b   Waldhausl W ^a   Maurer, G ^b   Kostner, G M ^c   Kostner, K ^b,d  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d Department of Cardiology ^*  (Austria)

Author keywords

Lp(a); Macroalbuminuria; Microalbuminuria; NIDDM; Urinary apo(a) excretion

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A; CREATININE; HEMOGLOBIN A1C; LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; URINARY EXCRETION;

AGED; APOLIPOPROTEINS A; BLOTTING, WESTERN; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPOPROTEIN(A); LIPOPROTEINS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS;

EID: 0031454870     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050849     Document Type: Article

References (35)

1. Berg K, Dahlen G, Frick MH (1974) Lp(a) lipoprotein and pre-β1-lipoprotein in patients with coronary heart disease. Clin Genet 6: 230-235
2. Kostner GM, Avogaro P, Cazzolato G, Marth E, Bittolobon G (1981) Lipoprotein Lp(a) and the risk for myocardial infarction. Atherosclerosis 38: 51-61
3. Armstrong VW, Cremer P, Eberle E et al. (1986) The association between serum Lp(a) concentrations and angio graphically assessed coronary atherosclerosis. Atherosclerosis 62: 249-257
4. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyana M (1986) Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 59: 199-204
5. Cushing GL, Gaubatz JW, Nava ML et al. (1989) Quantitation and localization of apolipoprotein(a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 9: 593-603
6. Cremer P, Nagel D, Labrot B et al. (1994) Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL-C and other risk factors: results from prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest 24: 444-453
7. McLean JW, Tomlinson JE, Kuang WJ et al. (1987) cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 300: 132-137
8. Edelberg JM, Pizzo SV (1991) Lp(a) inhibits plasminogen activation in a template dependent manner. Blood Coagul Fibrinolysis 2: 759-764
9. Bihari-Varga M, Gruber E, Rotheneder M, Zechner R, Kostner GM (1988) The Interaction of lipoprotein (a) and LDL with glycosamino glycans and proteoglycans from human aorta. Arterioscler Thromb 8: 851-857
10. Kannel WB, McGee DC (1979) Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59: 8-13
11. Assmann G, Schulte H (1988) The prospective cardiovascular Munster (PROCAM) Study: prevalence of hyperlipidaemia in persons with hypertension and diabetes mellitus and the relationship to coronary heart disease. Am Heart J 116:1713-1724
12. Haffner SM. Mosse SE, Klein BEK, Klein R (1992) Lack of association between lipoprotein(a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin epidemiologic study of diabetic retinopathy. Metabolism 41: 194-197
13. O'Brien T, Nguyen CTT, Harrison JM, Bailey KR, Dyck PJ, Kottke BA (1994) Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with NIDDM. Mayo Clin Proc 69: 430-435
14. Hiraga T, Kobayashi T, Okubo M et al. (1995) Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular diseases in patients with diabetes. Diabetes Care 18: 241-244
15. Kikuchi T, Onuma T, Shimura M et al. (1994) Different change in lipoprotein (a) levels from lipid levels of other lipoproteins with improved glycemic control in patients with NIDDM. Diabetes Care 17: 1059-1061
16. Heesen BJ, Wolfenbuttel BH, Leurs PB et al. (1993) Lipoprotein (a) levels in relation to diabetic complications in patients with non insulin dependent diabetes. Eur J Clin Invest 23: 580-584
17. Csaszar A, Dieplinger H, Sandholzer C et al. (1993) Plasma lipoprotein(a) concentrations and phenotypes in diabetes mellitus. Diabetoligia 36: 47-51
18. Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM (1994) Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes 43: 942-946
19. Haffner S, Morales PA, Stern M, Gruber MK (1992) Lp(a) concentrations in NIDDM. Diabetes 41: 1266-1272
20. Kuusi T, Yki Jarvinen H, Kauppinen et al. (1995) Effect of insulin treatment on serum lipoprotein (a) in non insulin dependant diabetes. Eur J Clin Invest 25: 194-200
21. Oida K, Takai H, Maeda H et al. (1992) Apolipoprotein (a) is present in urine and its excretion is decreased in patients with renal failure. Clin Chem 38/11: 2244-2248
22. Kostner K, Maurer G, Huber K et al. (1996) Urinary excretion of apo(a) fragments: role in apo(a) catabolism. Atheroscl Thromb 16/8: 905-911
23. Mooser V, Miguel CS, Moeen A, Landschulz K, Marcovina S, Hobbs HH (1996) Apolipoprotein(a) kringle 4-containing fragments in human urine. J Clin Invest 97: 858-864
24. Kostner K, Jansen M, Maurer G, Derfler K (1997) LDL-apheresis significantly reduces urinary apo(a) excretion. E J Clin Invest 27: 93-95
25. Kostner K, Huber K, Stefenelli T, Maurer G (1997) Urinary apo(a) discriminates between CAD and controls. Atherosclerosis 129: 103-110
26. Parra HJ, Mezdour H, Cachera C, Dracon M, Tacquet A, Fruchart JC (1987) Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 33: 721-722
27. Karadi I, Romics L, Palos G et al. (1989) Lp(a) concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 35: 2121-2123
28. Faucher C, Doucet C, Baumelou A, Chapman J, Jacobs C, Thillet J (1993) Elevated Lp(a) levels in primary nephrotic syndrome. Am J Kidney Dis 22: 808-813
29. Thomas ME, Freestone A, Varghese Z, Persaud JW, Moorhead JF (1992) Lp(a) in patients with proteinuria. Nephrol Dial Transplant 7: 597-601
30. Kronenberg F, Utermann G, Dieplinger H (1996) Lipoprotein (a) in renal disease. American Journal of Kidney Diseases 27: 1-25
31. Sidhu M, Crook D, Godsland IF, Walton C Wynn V, Oliver MF (1992) Inverse relationship between serum Lp(a) levels and first phase insulin secretion. Diabetes 41: 1341-1345
32. Levitsky LL, Scanu AM, Gould SH (1991) Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care 14: 283-287
33. Jenkins AJ, Steele JS, Janus AD, Santamaria JD, Best JD (1992) Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35: 1055-1059
34. Mooser V, Marcovina S, White A, Hobbs H (1996) Kringle-containing fragments of apolipoprotein (a) circulate in human plasma and are excreted into urine. J Clin Invest 10: 2414-1424
35. Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM (1994) Effects of NIDDM on lipoprotein (a) concentration and apolipoprotein size. Diabetes. 43: 942-946